Gwen Binder

Gwen Binder

Company: Cabaletta Bio

Job title: President, Science & Technology


Industry Leaders’ Fireside Chat: The Opportunity for Next-Gen 8:40 am

Instilling the importance for innovative platforms and technologies to further enhance cell therapy efficacy Reviewing clinical advances of next generation programmes across solid tumours and autoimmunityRead more

day: Conference Day 1 - AM

Modifying Gene Expression to Turbocharge Functionality of T-Cells 11:30 am

Manipulating expression of various genes to augment cell activity Lowering gene expression to increase stemness and persistence Armouring cells to prevent antigen escape and therapeutic resistanceRead more

day: Day 1 - Track A - AM

Next Generation Engineering to Armour Cell Therapies to Boost Potency in Solid Tumours
10:02 am

Read more

day: Day 1 - Track A - AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.